Medpage Today on MSN3d
Why Hospital Gowns Are Ugly; Mass Food Poisoning in Maryland; Eli Lilly Files Suit
In Washington state, four agricultural workers tested presumptively positive for avian influenza after contact with infected ...
The Pharma Letter1h
Lilly's Ebglyss demonstrated meaningful improvement in eczema
New results show Eli Lilly Ebglyss (lebrikizumab-lbkz) improved skin (including hand and face) and itch among patients with ...
FDA says this weight loss drug shortage is over, but patients worry about cost and availability
Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.
Roche comes out against allowing takeover of drug manufacturer Catalent
The CEO of pharmaceuticals giant Roche has urged authorities to block the takeover of contract drug manufacturer Catalent by ...
US Medicaid programs say cost a key factor for weight-loss drug coverage, survey finds
Most U.S. states do not currently cover highly sought after weight-loss drugs from Novo Nordisk and Eli Lilly in their ...
As insulin shortages persist, what diabetes patients can do
Advocates for diabetes patients who need insulin to survive worry the nation's supply is unreliable. Meanwhile, use of ...
AZ Central1d
Diabetes patients worry about insulin shortages as Ozempic use skyrockets
An Eli Lilly official said decades of insulin research and manufacturing ... the second most commonly prescribed medicine to ...
KSL2d
Medicaid programs say cost a key factor for weight-loss drug coverage, survey finds
Most U.S. states do not currently cover highly sought-after weight-loss drugs from Novo Nordisk and Eli Lilly in their ...
FiercePharma2d
Roche CEO says Novo's Catalent buyout 'could be a problem' for smaller drugmakers
The groups behind the letter alleged that Novo Nordisk’s plant purchases could hinder not only the Danish drugmaker’s chief ...
Can Roche Challenge Lilly and Novo in the Weight Loss Market?
Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
Analysis
Can Roche Holding Challenge Eli Lilly, Novo Nordisk in Weight Loss Market?
Eli Lilly and Company, Novo Nordisk A/S, Roche Holding Ltd ADR, Structure Therapeutics Inc ADR. Read MarketBeat.com (Leo Miller)'s latest article on Investing.com ...